1 – 20 of 27
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Factors affecting prognosis of MGUS and multiple myeloma
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2023
-
Mark
Abstract 5710: Detection and monitoring of t(11;14) in liquid biopsies from patients with relapsed/refractory multiple myeloma treated with venetoclax-based regimens
(
- Contribution to journal › Published meeting abstract
- 2020
-
Mark
Monoclonal gammopathy of undetermined significance in medical hospital admissions – a new strategy for screening?
(
- Contribution to journal › Debate/Note/Editorial
- 2017
-
Mark
Genomewide association study on monoclonal gammopathy of unknown significance (MGUS)
(
- Contribution to journal › Article
- 2015
-
Mark
Does Low-Molecular-Weight Heparin Influence the Antimyeloma Effects of Thalidomide? A Retrospective Analysis of Data from the GIMEMA, Nordic and Turkish Myeloma Study Groups
(
- Contribution to journal › Article
-
Mark
Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy
(
- Contribution to journal › Article
- 2014
-
Mark
Cancer risk in amyloidosis patients in Sweden with novel findings on non-Hodgkin lymphoma and skin cancer
(
- Contribution to journal › Article
-
Mark
Inherited genetic susceptibility to multiple myeloma
(
- Contribution to journal › Scientific review
- 2013
-
Mark
B cell lymphoma and myeloma in murine Gaucher's disease
(
- Contribution to journal › Article
- 2012
-
Mark
Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study
(
- Contribution to journal › Article
-
Mark
Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders
(
- Contribution to journal › Article
- 2011
-
Mark
Physical activity and lymphoid neoplasms in the European Prospective Investigation into Cancer and nutrition (EPIC)
(
- Contribution to journal › Article
- 2010
-
Mark
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
(
- Contribution to journal › Scientific review
-
Mark
Monoclonal gammopathy of undetermined significance: to screen or not to screen for multiple myeloma? - response
(
- Contribution to journal › Letter
- 2009
-
Mark
UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)
(
- Contribution to journal › Article
-
Mark
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
(
- Contribution to journal › Scientific review
-
Mark
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)
(
- Contribution to journal › Article
-
Mark
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
(
- Contribution to journal › Scientific review
- 2007
-
Mark
Serum calcium is an independent predictor of quality of life in multiple myeloma
(
- Contribution to journal › Article
-
Mark
In the shadow of bad news - views of patients with acute leukaemia, myeloma or lung cancer about information, from diagnosis to cure or death
(
- Contribution to journal › Article